Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer

By Farrow D.C.  

Cancer Causes and Control, Vol. 11, Iss. 3, 2000-03 ,pp. : 231-238

Springer Publishing Company

Access to resources Recommend Favorite

Design and Synthesis of Some Novel Estrogen Receptor Modulators as Anti-Breast Cancer Agents: In Vitro In Vivo Screening, Docking Analysis

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 11, 2016-10 ,pp. : 1461-1467

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of histamine and histamine 2 receptor antagonists on quality of life and antitumour responses: results of a pilot trial

By Milanese S.   Hansen L.A.   Desch C.E.   Honeycutt C.   Tesfaye F.   Smith T.J.  

European Journal of Cancer, Vol. 33, Iss. 14, 1997-12 ,pp. : 2436-2437

Elsevier

Access to resources Recommend Favorite

Receptor occupancy theory-based analysis of antiemetic effects and standard doses of 5-HT₃ receptor antagonists in cancer patients

By Yamada Yasuhiko   Sugiura Munetoshi   Higo Kozue   Ozeki Takeshi   Takayanagi Risa   Okuyama Kiyoshi   Yamamoto Koujirou   Satoh Hitoshi   Sawada Yasufumi   Iga Tatsuji  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 2, 2004-08 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite

A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis

By Jordan K.   Hinke A.   Grothey A.   Voigt W.   Arnold D.   Wolf H.-H.   Schmoll H.-J.  

Supportive Care in Cancer, Vol. 15, Iss. 9, 2007-09 ,pp. : 1023-1033

Springer Publishing Company

Access to resources Recommend Favorite